G108R system, the latest generation of our commercialized DBS products, was approved for marketing by the  NMPA in 2026.

Our rechargeable directional Bluetooth-sensing DBS product was recognized as one of the “Top Ten Brain-Computer Interface Innovations of 2025”...

We obtained regulatory approval for the first domestically developed rechargeable and non-rechargeable directional DBS product.

We were designated as a National Enterprise Technology Center.
We  received  NMPA approval  for  the  first  domestically  developed  rechargeable,  Bluetooth-sensing,  and MRI-compatible DBS product.

We launched our first SCS product, the G122 system, which is the first domestically developed SCS product in China.
We received NMPA approval for our 3.0T MRI-compatible DBS product.

Our DBS product was awarded the title of “Manufacturing Industry Single Champion Product” by the Ministry of Industry and Information Technology...

We successfully completed clinical trials of our “AI+ Deep Brain Stimulator.”

Awarded the First Prize of the National Science and Technology Progress Award .
Launched  first SNM product, the G131 system, which is the first domestically developed SNM product in China.

Our DBS product was successfully implanted in Pakistan, marking the first overseas implantation of a domestically developed DBS product.

We launched our first VNS product, the G111 system, which is the first domestically developed VNS product in China...

The project “DBS Technology, System and Clinical Application” was awarded the First Prize of the Beijing Science and Technology Award.

Our first DBS product, the G101 system, was approved for marketing by the NMPA in 2013, marking the first domestically developed DBS product in China.

Our DBS achievement was selected for inclusion in the “11th Five-Year Plan Major Scientific and Technological Achievements Exhibition.

We successfully completed the first clinical trial of our DBS product for the treatment of Parkinson’s disease.

Our Company was incorporated in the PRC.